VALIANT LABORATORIES
Back to All Ratios
|
VALIANT LABORATORIES Last 5 Year EV/Core EBITDA History
[Consolidated]
Mar2024 | Mar2023 | |
---|---|---|
EV/Core EBITDA(x) | 472.93 | 2.27 |
What is the latest EV/Core EBITDA ratio of VALIANT LABORATORIES ?
Year | EV/Core EBITDA |
---|---|
Mar2024 | 472.93 |
Mar2023 | 2.27 |
How is EV/Core EBITDA of VALIANT LABORATORIES Trending?
Years | EV/Core EBITDA | % Change | |
---|---|---|---|
Mar2024 | 472.93 | 20,733.92 | |
Mar2023 | 2.27 | - |
Other Financial Ratios of VALIANT LABORATORIES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Core EBITDA ratio of peers of VALIANT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VALIANT LABORATORIES | ₹490.5 Cr | -2.6% | -6% | -18.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
VALIANT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VALIANT LABORATORIES | -2.6% |
-6% |
-18.3% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses